ATHENS, Griekenland--(BUSINESS WIRE)--GENESIS Pharma, een regionaal biofarmaceutisch bedrijf gespecialiseerd in het op de markt brengen van innovatieve geneesmiddelen voor ernstige en zeldzame ziekten in Centraal- en Oost-Europa, kondigt…
ATENE, Grecia--(BUSINESS WIRE)--GENESIS Pharma, azienda biofarmaceutica regionale specializzata nella commercializzazione di farmaci innovativi per il trattamento di malattie gravi e rare nell'Europa centrale e orientale, ha annunciato…
ATHENS, Greece--(BUSINESS WIRE)--GENESIS Pharma announces an exclusive distribution agreement with Regeneron Pharmaceuticals to commercialize cemiplimab in Greece, Cyprus and Malta.
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that the company will present findings from four studies evaluating apraglutide in adults with short bowel syndrome…
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed Richard Baxter to the role of Senior Vice President of Investment Operations, and Karen Reeves, M.D., to Senior Vice…
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs in virology and immunology, today reported financial results for its fiscal…
BERWYN, Pa.--(BUSINESS WIRE)-- #pharma--Virpax Announces Preliminary Results of Probudur™ Pilot Study with the U.S. Army Institute of Surgical Research
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer,…
New York, United State, Jan. 23, 2024 (GLOBE NEWSWIRE) -- A plant extract is a substance or active ingredient with desirable properties used for a particular purpose. Usually, a solvent is used to extract it from plant tissues. Plant…
LA JOLLA, Calif.--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today…
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today…
LA JOLLA, Calif.--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today…
SUWON, South Korea--(BUSINESS WIRE)-- #AMD--OliX Pharmaceuticals, Inc. received approval from the HREC to conduct a Phase 1 clinical trial of drug candidate OLX75016
Phase 3 RESILIENT study of TNX-102 SL successfully demonstrated daily pain reduction over placebo (primary endpoint, p = 0.00005) All six key secondary endpoints, including patient global impression, fibromyalgia-specific…
Part 5 data reinforces favorable safety and tolerability profile and long-term efficacy results for SerpinPC: Median all-bleed ABR of 1.0, a 96% reduction from prospective baseline No thromboembolic events or treatment-related…
Newswise — WASHINGTON (March 8, 2023)--Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive…
05/12/2019 - India is set for a modest recovery after a loss of momentum, as reforms to simplify taxation, lighten business regulations and upgrade infrastructure start to bear fruit. Further reforms to!--body-start-->…
SMi Group reports: Exclusive speaker interview released with Takeda Pharmaceutical Company Ltd ahead of the Highly Potent API Conference
LONDON, NON UNITED STATES OR CANADA, UNITED KINGDOM, April 8, 2022 /EINPresswire.com/ -- Now…
Ferrer has achieved a score of 100.6 points and is among only 25% of B Corps worldwide that have exceeded 100 points.
BARCELONA, Spain, January 26, 2022 (Newswire.com)
-
Ferrer, the…
DUBLIN, March 22, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will participate in a fireside chat at the Stifel 2022 CNS Days on Tuesday, March 29, 2022 at 8:30 a.m.…
Knowledge @ Wharton and Momentum Host The Cuba Opportunity Summit, April 1 at the Nasdaq Marketsite in Times Square, NYCPhilippe Pouletty ChairmanAbivaxSteven G. Ullmann Professor and Director, Programs in and Center for Health Sector…
CEO of FORUM Pharma, Deborah Dunsire, discusses the company, its focus on serious brain diseases and the IPO window. Says #BIO2014 provides ability to connect.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
AcceptRead More